Chemical Compound

Dapagliflozin

CAS Registry Number 461432-26-8
Dapagliflozin chemical structure
Primary Record

Dapagliflozin

In stock
6,778 g
Purity
98.1 %
CAS
461432-26-8

Compound Identifiers & Properties

CAS
461432-26-8
PubChem CID
9887712
SMILES
CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Cl
Canonical SMILES
CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1

Names & Synonyms

  • Dapagliflozin
  • 461432-26-8
  • Forxiga
  • Farxiga
  • dapagliflozine
  • BMS-512148
  • Dapagliflozina
  • Dagagflozin
  • dapagliflozinum
  • dapaglifozin
  • Dapagliflozin [USAN]
  • Forxiga (TN)
  • 1ULL0QJ8UC
  • DAPAGLIFLOZIN?
  • S1548_Selleck
  • C-aryl glucoside, 6
  • UNII-1ULL0QJ8UC
  • BMS 512148
  • Tube101
  • Dapagliflozin propanediol
  • RefChem:54930
  • Dapagliflozin (Standard)
  • Dapagliflozin [USAN:INN]
  • DAPAGLIFLOZIN [MI]
  • MFCD13182359
  • D01TNW
  • DAPAGLIFLOZIN [INN]
  • Dapagliflozin (INN/USAN)
  • LYN-045
  • CHEMBL429910
  • BMS512148
  • C21H25ClO6
  • DAPAGLIFLOZIN [VANDF]
  • cc-205
  • CHEBI:85078
  • Dapagliflozin/BMS-512148
  • SCHEMBL157820
  • DTXSID20905104
  • DAPAGLIFLOZIN [WHO-DD]
  • BMS-512148, Dapagliflozin
  • GLU006
  • GTPL4594
  • orb1305553
  • orb3012985
  • BR1019 component Dapagliflozin
  • CHEMBL3125316
  • CHEMBL3125317
  • CHEMBL3125318
  • CHEMBL3125455
  • CHEMBL3125456
  • CHEMBL3125457
  • CHEMBL3125458
  • Dapagliflozin (JAN/USAN/INN)
  • SCHEMBL29364603
  • BDBM20880
  • A10BK01
  • EX-A005
  • Dapagliflozin - Bio-X trade mark
  • JVHXJTBJCFBINQ-ADAARDCZSA-N
  • BCPP000265
  • DTXCID101334207
  • GLXC-90177
  • DAPAGLIFLOZIN [ORANGE BOOK]
  • DAPAGLIFLOZIN COMPONENT QTERNMET
  • AMX10145
  • AMY18541
  • AOB87300
  • dapagliflozin propanediol monohydrate
  • KS-000006UW
  • MSK11068
  • ZINC3819138
  • (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol
  • (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
  • AN-431
  • BDBM50448923
  • CD0219
  • EBC-11348
  • HY-10450R
  • s1548
  • QTERNMET COMPONENT DAPAGLIFOZIN
  • AKOS005145763
  • QTERNMET XR COMPONENT DAPAGLIFLOZIN
  • ACN-028597
  • BCP9000583
  • BL-0052
  • BMS5121458
  • CCG-229917
  • CID9887712
  • CS-0781
  • CS-O-11248
  • DB06292
  • EX-7214
  • MD20795
  • RL03723
  • Dapagliflozin propylene glycolate hydrate
  • NCGC00250402-09
  • AC-24699
  • AJ-45726
  • BD164346
  • HY-10450
  • SC-25116
  • SY028092
  • AB1008441
  • (2S,3R,4R,5S,6R)-2-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-6-(hydroxymethyl)oxane-3,4,5-triol
  • 5168A
  • A5854
  • NS00099173
  • ST24046416
  • J2.928.717A
  • A10285
  • A25150
  • C22193
  • D08897
  • Q-3845
  • EN300-7407160
  • 432D268
  • Q409898
  • BRD-K58160573-001-01-3
  • BRD-K58160573-001-04-7
  • BRD-K58160573-001-05-4
  • Z2235801883
  • B0084-069214
  • BMS-512148, 461432-26-8
  • D-Glucitol, 1,5-anhydro-1-C-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-, (1S)-
  • (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
  • 1-[3-(beta-D-Glucopyranosyl)-6-chlorobenzyl]-4-ethoxybenzene
  • 1-[3-(4-Ethoxybenzyl)-4-chlorophenyl]-1-deoxy-beta-D-glucopyranose
  • 1-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-1-deoxy-beta-D-glucopyranose
  • 2-(3-(4-Ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
  • D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-
  • (1S)-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol
  • (2S,3R,4R,5S,6R)-2-[4-chloranyl-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
  • (2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
  • (2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
  • (2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
  • 960404-48-2
  • (1S)-1,5-Anhydro-1-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-D-glucitol
  • (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol; (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; (2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; BMS 512148; Dapagliflozin; Farxiga
  • (2S, 3R, 4R, 5S, 6R)-2-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol
  • (2S,3R,4R,5S,6R)-2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol
  • (2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-6-(hydroxymethyl)oxane-3,4,5-triol
  • (2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol
  • (2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
  • 639-683-0
  • LE6